EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health Holdings Limited (NASDAQ:EUDA) was the recipient of a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 145,762 shares, an increase of 47.4% from the January 29th total of 98,870 shares. Based on an average daily trading volume, of 123,970 shares, the short-interest ratio is presently 1.2 days. Currently, 0.4% of the company’s shares are sold short. Currently, 0.4% of the company’s shares are sold short. Based on an average daily trading volume, of 123,970 shares, the short-interest ratio is presently 1.2 days.

EUDA Health Trading Up 7.3%

NASDAQ:EUDA opened at $0.97 on Friday. EUDA Health has a 1 year low of $0.71 and a 1 year high of $4.30. The stock has a 50-day moving average price of $1.58 and a two-hundred day moving average price of $2.10. The stock has a market cap of $36.85 million, a price-to-earnings ratio of -8.12 and a beta of -0.15.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, EUDA Health presently has a consensus rating of “Sell”.

Institutional Trading of EUDA Health

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC raised its stake in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 44,631 shares of the company’s stock after buying an additional 16,321 shares during the quarter. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.